Ardelyx (ARDX) Net Cash Flow Growth (5y) (2018 - 2026)
Ardelyx (ARDX) Net Cash Flow Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.51% |
| Dec 31, 2025 | 305.72% |
| Sep 30, 2025 | -37.92% |
| Jun 30, 2025 | 66.94% |
| Mar 31, 2025 | 14.63% |
| Dec 31, 2024 | -27.68% |
| Sep 30, 2024 | 12.70% |
| Jun 30, 2024 | 34.39% |
| Mar 31, 2024 | 2.04% |
| Dec 31, 2023 | -39.47% |
| Sep 30, 2023 | 17.31% |
| Jun 30, 2023 | -35.69% |
| Mar 31, 2023 | 13.72% |
| Dec 31, 2022 | 16.72% |
| Sep 30, 2022 | 31.72% |
| Jun 30, 2022 | 23.18% |
| Mar 31, 2022 | -49.58% |
| Dec 31, 2021 | 49.35% |
| Sep 30, 2021 | -23.19% |
| Jun 30, 2021 | 16.07% |